Introduction {#S1}
============

This summary of the 2007 ERA-EDTA Registry Report includes data on renal replacement therapy (RRT) from 49 national and regional registries in 28 countries in Europe and bordering the Mediterranean Sea (Figure [1](#F1){ref-type="fig"}). Data sets with individual patient data for analysis were received from 34 registries, whereas 17 registries contributed data only in aggregated form. For both types of registries, we present incidence and prevalence data as well as transplant rates. Survival analysis used the data from countries and regions that provided individual patient records. More detailed data than those presented in this paper can be found in the 2007 ERA-EDTA Registry Report \[[@R1]\] that is also available on www.era-edta-reg.org.

![Incidence of RRT per million population (pmp) at Day 1, 2007. B&H = Bosnia--Herzegovina; FYROM = Former Yugoslav Republic of Macedonia.](sfp126fig1){#F1}

The incidence of RRT for ESRD across Europe {#S2}
===========================================

In 2007, the overall incidence rate of RRT for end-stage renal disease (ESRD) among all registries reporting to the ERA-EDTA Registry was 116 per million population (pmp). Figure [2](#F2){ref-type="fig"} shows that the highest incidence rates at Day 1 were reported by Turkey (231 pmp), Portugal (227 pmp) and Israel (193 pmp), whereas incidence rates below 100 pmp were reported by Ukraine (20 pmp), Russia (31 pmp), Montenegro (32 pmp), Iceland (81 pmp), Latvia (86 pmp), Romania (90 pmp), Finland (92 pmp) and FYR of Macedonia (92 pmp). The mean age at the start of RRT ranged from 43 years (Ukraine) to 69 years (Belgium) (Figure [2](#F2){ref-type="fig"}). Table [1](#T1){ref-type="table"} shows the incidence rate of RRT over the period 2003--2007 for countries and regions providing individual patient data, adjusted for age and gender distribution.

![Incidence of RRT per million population (pmp) and mean age (years) at Day 1 in 2007, unadjusted. Figures include data from renal registries providing individual patient data (left figure) and aggregated data (right figure). Data of Estonia and Tunisia are based on Day 91 of RRT.](sfp126fig2){#F2}

###### 

Incidence of RRT over the period 2003--2007 per million population (pmp) at Day 1, adjusted for age and gender distribution

  Country /regions                                   
  -------------------------- ----- ----- ----- ----- -----
  Austria                    138   156   148   153   146
  Belgium, Dutch-speaking    160   163   163   169   161
  Belgium, French-speaking   156   179   171   180   178
  Denmark                    133   131   119   117   136
  Finland                    93    94    92    83    85
  Greece                     168   177   171   172   164
  Iceland                    83    87    81    79    84
  Italy, Calabria            130   137   127   121   132
  Norway                     97    102   101   101   113
  Spain, Andalusia           137   138   141   139   125
  Spain, Aragon              87    114   119   93    113
  Spain, Asturias            108   132   101   102   103
  Spain, Basque country      128   112   107   99    98
  Spain, Cantabria           126   135   142   115   99
  Spain, Castile and Leon    98    100   91    101   99
  Spain, Castile-La Mancha   105   113   125   109   102
  Spain, Catalonia           144   132   141   125   130
  Spain, Valencian region    148   157   140   144   137
  Sweden                     113   113   110   117   117
  The Netherlands            108   110   109   114   117
  United Kingdom, England    73    86    107   111   107
  United Kingdom, Scotland   117   110   119   109   106
  United Kingdom, Wales      121   112   122   126   129
  All countries              111   118   123   124   122

For the age group 0--19 years at the start of RRT, data were available for a limited number of registries including those of Austria, Denmark, Finland, Greece, Iceland, Norway, Romania, Spain (Andalusia), Spain (Aragon), Spain (Basque country), Spain (Catalonia), Spain (Valencian region), Sweden, The Netherlands, and United Kingdom (Scotland). As numbers of children starting RRT were low, we present averages for 2006--2007 (Table [2](#T2){ref-type="table"}). In 2007, the ERA-EDTA Registry started a close collaboration with the ESPN/ERA-EDTA Registry that initiated data collection from paediatric registries across Europe \[[@R2]\]. For an overview of paediatric RRT data collected from those registries, please visit www.espn-reg.org.

###### 

Incidence of RRT over the period 2006--2007 per million age-related population (pmarp) per year at Day 1, by age group, unadjusted

               0--19   0--4   5--9   10--14   15--19
  ------------ ------- ------ ------ -------- --------
  2006--2007   10      8      5      8        16

Table [3](#T3){ref-type="table"} shows the incidence rate of RRT by age group, for countries and regions providing individual patient data. For the highest age groups, the highest incidence rates were reported from Belgium and Greece, whereas Finland and Romania belong to the countries reporting the lowest incidence rates.

###### 

Incidence of RRT per million age related population (pmarp) at Day 1 in 2007, by age group, unadjusted

  Country/regions                                          
  ---------------------------------- ---- ---- ----- ----- -----
  Austria                            10   41   191   488   551
  Belgium, Dutch-speaking                 39   171   542   899
  Belgium, French-speaking                34   209   649   848
  Denmark                            10   51   179   435   524
  Finland                            11   40   132   231   238
  Greece                             9    43   188   536   839
  Iceland                            11   45   137   163   340
  Italy (12 of 20 regions)           7    42   143   406   561
  Norway                             6    42   151   381   416
  Romania                            8    47   161   251   136
  Spain, Andalusia                   9    46   160   442   437
  Spain, Aragon                      9    47   136   490   304
  Spain, Asturias                         44   141   323   378
  Spain, Basque country              3    38   132   340   326
  Spain, Cantabria                        41   145   362   263
  Spain, Castile and Leon                 34   128   378   358
  Spain, Castile-La Mancha                31   145   360   369
  Spain, Catalonia                   7    44   176   402   523
  Spain, Valencian region            8    51   187   392   582
  Sweden                             9    44   156   396   428
  The Netherlands                    10   42   147   393   448
  United Kingdom, All countries           55   154   331   334
  United Kingdom, England                 55   153   325   321
  United Kingdom, Northern Ireland        42   141   463   493
  United Kingdom, Scotland           15   59   158   278   317
  United Kingdom, Wales                   54   163   435   491

The incidence rates of RRT for ESRD due to diabetes mellitus were highest in Israel (81 pmp), Turkey (64 pmp), and Slovakia (60 pmp), whereas the highest incidence rates of RRT for ESRD due to hypertension/renal vascular disease were reported from Turkey (58 pmp), and Belgium (52 pmp) (Table [4](#T4){ref-type="table"}).

###### 

Incidence of RRT per million population (pmp) at Day 1 in 2007, by primary renal disease, unadjusted

  Country/regions                               HT/             Unkn/
  ---------------------------------- ----- ---- ----- ---- ---- -------
  Austria                            152   48   34    16   37   17
  Belgium, Dutch-speaking            186   44   52    19   56   16
  Belgium, French-speaking           185   42   52    19   64   8
  Denmark                            141   32   18    15   50   27
  Finland                            92    32   6     11   24   18
  Greece                             190   53   22    16   37   62
  Iceland                            81    10   35    6    26   3
  Italy (12 of 20 regions)           150   30   36    16   35   34
  Norway                             113   15   35    19   40   4
  Romania                            90    11   6     15   30   28
  Spain, Andalusia                   121   27   20    16   33   25
  Spain, Aragon                      130   31   24    24   41   11
  Spain, Asturias                    133   28   21    10   33   41
  Spain, Basque country              113   17   25    12   42   17
  Spain, Cantabria                   111   19   36    40   12   4
  Spain, Castile and Leon            127   32   22    14   33   26
  Spain, Castile-La Mancha           109   33   14    12   30   20
  Spain, Catalonia                   137   28   23    19   32   34
  Spain, Valencian region            145   25   37    18   33   32
  Sweden                             129   35   25    16   38   14
  The Netherlands                    118   21   26    11   28   32
  United Kingdom, All countries      111   23   12    13   31   32
  United Kingdom, England            109   22   11    12   30   33
  United Kingdom, Northern Ireland   114   26   16    12   44   17
  United Kingdom, Scotland           114   20   13    13   41   27
  United Kingdom, Wales              142   36   15    25   32   34
  Bosnia-Herzegovina                 164   33   16    14   70   31
  Czech Republic                                                
  Estonia                                                       
  France (18 of 24 regions)          139   31   36    16   37   19
  FYR of Macedonia                   92    21   24    7    21   19
  Israel                             193   81   19    9    28   57
  Italy (14 of 20 regions)           145   29   36    15   33   32
  Latvia                             86    15   11    11   40   10
  Montenegro                         32    18   6     3    5    
  Poland                             128   32   17    23   38   17
  Portugal                                                      
  Russia                             31    5    2     11   11   2
  Slovakia                           160   60   16    13   63   7
  Spain (17 of 19 regions)           126   30   22    16   32   26
  Tunisia                                                       
  Turkey                             231   64   58    24   41   45
  Ukraine                            20    3    1     10   6    1

DM: diabetes mellitus; HT: hypertension; RVD: renal vascular disease; GN: glomerulonephritis/sclerosis; others include pyelonephritis, polycystic kidneys, adult type and miscellaneous; Unkn: unknown.

Categories may not add up because of rounding off.

When cells are left empty, (complete) data are unavailable.

The prevalence of RRT for ESRD across Europe {#S3}
============================================

The overall prevalence among all registries reporting to the ERA-EDTA Registry was 662 pmp. Figure [3](#F3){ref-type="fig"} shows that the prevalence of RRT pmp at 31 December 2007 was highest in Portugal (1372 pmp), Belgium (French-speaking) (1109 pmp) and Spain (Catalonia) (1100 pmp). The lowest prevalence was reported by Ukraine (85 pmp) and Russia (146 pmp). The mean age at 31 December 2007 ranged from 44 years (Russia and Ukraine) to 64 years (Belgium, Dutch speaking) for registries providing data both on dialysis and transplant patients (Figure [3](#F3){ref-type="fig"}). Table [5](#T5){ref-type="table"} shows the overall prevalence of RRT, adjusted for age and gender distribution.

![Prevalence of RRT per million population (pmp) and mean age (years) on 31 December 2007, unadjusted. Figures include data from renal registries providing individual patient data (left figure) and aggregated data (right figure). Data from Czech Republic, Israel, Italy (14 of 20 regions), Slovakia and Tunisia include dialysis patients only, and in Italy (12 of 20 regions) the percentage of missing prevalent RRT patients is estimated at 11%, due to an estimated 25--30% underreporting of patients living on a functioning graft.](sfp126fig3){#F3}

###### 

Prevalence of RRT on 31 December over the period 2003--2007 per million population (pmp), adjusted for age and gender distribution

  Country/region                                         
  -------------------------- ------ ------ ------ ------ ------
  Austria                    794    829    854    875    894
  Belgium, Dutch-speaking    848    876    908    939    962
  Belgium, French-speaking   929    978    1010   1054   1087
  Denmark                    730    751    760    768    798
  Finland                    642    659    680    686    699
  Greece                     848    851    872    885    900
  Iceland                    535    532    527    526    551
  Italy, Calabria            897    906    909    913    928
  Norway                     687    725    743    763    791
  Spain, Andalusia           939    968    999    996    981
  Spain, Aragon              699    727    755    769    792
  Spain, Asturias            765    814    827    835    837
  Spain, Basque country      872    902    937    948    965
  Spain, Cantabria           722    746    747    745    736
  Spain, Castile and Leon    742    764    776    784    779
  Spain, Castile-La Mancha   865    867    897    900    901
  Spain, Catalonia           1007   1037   1028   1028   1060
  Spain, Valencian region    1022   1058   1044   1047   1050
  Sweden                     753    772    783    804    816
  The Netherlands            691    711    736    768    791
  United Kingdom, England    441    538    690    712    742
  United Kingdom, Scotland   707    717    741    759    782
  United Kingdom, Wales      658    663    685    710    780
  All countries              686    733    798    815    834

Only a limited number of registries provided complete data for prevalent patients in the age group 0--19 years in 2007, including those of Austria, Denmark, Finland, Greece, Iceland, Norway, Romania, Spain (Andalusia), Spain (Aragon), Spain (Basque country), Spain (Catalonia), Spain (Valencian region), Sweden, The Netherlands and United Kingdom (Scotland). The prevalence for age group 0--19 years is presented in Table [6](#T6){ref-type="table"}.

###### 

Prevalence of RRT per million age-related population (pmarp) on 31 December 2007, by age group, unadjusted

         0--19   0--4   5--9   10--14   15--19
  ------ ------- ------ ------ -------- --------
  2007   57      19     38     57       108

Table [7](#T7){ref-type="table"} shows that for the highest age groups, the highest prevalence was reported by Belgium, Greece, Italy, and several Spanish registries.

###### 

Prevalence of RRT per million age related population (pmarp) on 31 December 2007, by age group, unadjusted

  Country/regions                                              
  ---------------------------------- ----- ----- ------ ------ ------
  Austria                            59    461   1558   2417   1829
  Belgium, Dutch-speaking                  410   1450   2709   3466
  Belgium, French-speaking                 484   1698   3072   3322
  Denmark                            65    562   1273   1957   1662
  Finland                            110   432   1237   1559   1220
  Greece                             50    428   1395   2532   2764
  Iceland                            68    454   819    1035   1303
  Italy (12 of 20 regions)           41    402   1350   2566   3024
  Norway                             61    494   1308   2054   1618
  Romania                            21    228   728    825    396
  Spain, Andalusia                   61    509   1653   2623   2213
  Spain, Aragon                      30    398   1394   2119   1867
  Spain, Asturias                          489   1404   2243   1810
  Spain, Basque country              122   501   1629   2549   2032
  Spain, Cantabria                         380   1340   2031   1383
  Spain, Castile and Leon                  445   1373   2024   1732
  Spain, Castile-La Mancha                 446   1613   2542   1831
  Spain, Catalonia                   57    467   1775   2967   2800
  Spain, Valencian region            58    480   1705   2913   2966
  Sweden                             66    488   1439   2063   1610
  The Netherlands                    68    484   1254   2095   1731
  United Kingdom, All countries            535   1232   1809   1462
  United Kingdom, England                  526   1227   1812   1436
  United Kingdom, Northern Ireland         545   1294   2275   2097
  United Kingdom, Scotland           76    620   1253   1683   1259
  United Kingdom, Wales                    536   1257   1754   1892

Renal transplants {#S4}
=================

Figure [4](#F4){ref-type="fig"} shows that the highest transplant rates were reported from Spain (Cantabria) (71 pmp), Spain (Catalonia) (65 pmp) and Norway (55 pmp). Countries with the highest transplant rates with living donor kidneys included Iceland (23 pmp), The Netherlands (23 pmp) and Norway (18 pmp).

![Renal transplants performed per million population (pmp) in 2007, by donor type, unadjusted. Figures include data from renal registries providing individual patient data (left figure) and aggregated data (right figure).](sfp126fig4){#F4}

Patient and graft survival {#S5}
==========================

Survival analysis used the data from 20 registries in 12 countries that provided individual patient records for the periods 1998--2002 and 2001--2005. Data are presented for all countries and regions together (Table 8 and Figures 5--7). Comparisons of survival by treatment modality were all adjusted for fixed values of age, gender and distribution of PRD. Similar adjustments have been applied to survival comparisons by PRD (please, consult appendix for fixed values and further methodology).

![Survival of incident dialysis patients and of patients receiving a first transplant between 1998--2002, by treatment modality, adjusted for age, gender and primary renal disease.](sfp126fig5){#F5}

![Survival of incident haemodialysis patients in 1998--2002, from Day 91, by primary renal disease, adjusted for age and gender.](sfp126fig6){#F6}

![Survival of incident peritoneal dialysis patients in 1998--2002, from Day 91, by primary renal disease, adjusted for age and gender.](sfp126fig7){#F7}

###### 

One-, 1- and 5-year survival probabilities, unadjusted^a^

                                                             Cohort 1998--2002   Cohort 2001--2005                                           
  ---------------------------------------------------------- ------------------- ------------------- ------------------- ------------------- -------------------
  Patient survival on RRT                                    80.9 (80.7--81.2)   69.3 (69.0--69.5)   46.1 (46.0--46.3)   80.9 (80.6--81.1)   69.5 (69.3--69.7)
  Patient survival on dialysis                               80.3 (80.0--80.5)   67.2 (67.0--67.5)   38.3 (38.2--38.5)   80.2 (79.9--80.4)   67.6 (67.3--67.8)
  Patient survival after first transplant (deceased donor)   95.6 (95.3--96.0)   93.7 (93.2--94.1)   86.6 (86.1--87.2)   95.6 (95.3--96.0)   93.7 (93.3--94.0)
  Patient survival after first transplant (living donor)     97.7 (97.0--98.1)   96.9 (96.2--97.5)   94.0 (93.1--94.7)   97.4 (96.8--97.9)   96.6 (96.0--97.1)
  Graft survival after first transplant (deceased donor)     90.0 (89.5--90.5)   87.0 (86.5--87.6)   77.5 (76.9--78.1)   90.0 (89.5--90.4)   87.1 (86.5--87.5)
  Graft survival after first transplant (living donor)       94.4 (93.5--95.2)   92.6 (91.7--93.5)   86.0 (84.9--87.1)   93.8 (93.0--94.5)   92.0 (91.2--92.8)

^a^For analysis methods, see the appendix.
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To Table 8 {#S6}
==========

Data presented include the survival of incident patients on RRT and of patients receiving a first transplant between 1998--2002 or between 2001--2005 with their 95% confidence intervals. The patients were followed until 31 December 2007. Statistical analysis of unadjusted survival was performed by the Kaplan--Meier method.

For the analysis of patient survival on RRT, the day at the start of RRT was taken as the starting point and the event studied was death. Censored observations were recovery of renal function, loss to follow-up and end of follow-up time.

For the analysis of patient survival on dialysis, the first day on dialysis was the starting point, the event was death and reasons for censoring were recovery of renal function, loss to follow-up, end of follow-up time and renal transplantation.

For the analysis of patient and graft survival after transplantation, the date of the first renal transplantation was defined as the first day of follow-up.

For the patient survival after transplantation, the event studied was death and for the graft survival the events were graft failure and death. Reasons for censoring were loss to follow-up and end of follow-up time.

To Figure [5](#F5){ref-type="fig"} {#S7}
==================================

For the analyses of patient survival on dialysis the starting point was Day 91 on dialysis. Analyses were adjusted for the fixed values of age (60 years), gender (60% men) and primary renal disease (20% diabetes mellitus, 17% hypertension/renal vascular disease, 15% glomerulonephritis and 48% other cause).

For the analyses of patient survival after transplantation, the starting point was the time of the first transplant. The analyses were adjusted for the fixed values of age (45 years), gender (60% men) and primary renal disease (10% diabetes mellitus, 8% hypertension/renal vascular disease, 28% glomerulonephritis and 54% other cause).

To Figures [6](#F6){ref-type="fig"} and [7](#F7){ref-type="fig"} {#S8}
================================================================

For the analyses presented in each figure, the starting point was Day 91 on dialysis. The analyses were adjusted for the fixed values of age (60 years) and gender (60% men).
